Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Recht

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
Blood Advances|June 4, 2020
Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation StudyBeth Boulden Warren, Dianne Thornhill, Jill Stein, et al.
Journal of Thrombosis and Haemostasis : JTH|March 16, 2025
Corticosteroid use to mitigate transaminitis-associated decline in FVIII levels following valoctocogene roxaparvovec gene therapy: clinical practice guidanceBarbara A Konkle, Flora Peyvandi, Graham R Foster, et al.
Pediatric Blood & Cancer|June 1, 2012
Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenonYvonne E Chiu, Beth A Drolet, Francine Blei, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 19, 2023
Observational cohort study of long-term outcomes of liver transplantation in haemophiliaMargaret V Ragni, Jessica Callis, Nabil Daoud, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 25, 2019
Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS)Johnny Mahlangu, Johannes Oldenburg, Michael U Callaghan, et al.
Journal of Blood Medicine|October 28, 2021
Integrated Hemophilia Patient Care via a National Network of Care Centers in the United States: A Model for Rare Coagulation DisordersLeonard A Valentino, Judith R Baker, Regina Butler, et al.
Blood Advances|December 9, 2022
Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapyAnnette von Drygalski, Esteban Gomez, Adam Giermasz, et al.
Transfusion|May 11, 2013
Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentratesJ Michael Soucie, Paul E Monahan, Roshni Kulkarni, et al.
Transfusion|September 25, 2012
Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screeningJ Michael Soucie, Christine De Staercke, Paul E Monahan, et al.
Journal of Thrombosis and Haemostasis : JTH|June 30, 2022
Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United StatesJill M Johnsen, Shelley N Fletcher, Angela Dove, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Blood Advances|June 4, 2020
Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation StudyBeth Boulden Warren, Dianne Thornhill, Jill Stein, et al.
Journal of Thrombosis and Haemostasis : JTH|March 16, 2025
Corticosteroid use to mitigate transaminitis-associated decline in FVIII levels following valoctocogene roxaparvovec gene therapy: clinical practice guidanceBarbara A Konkle, Flora Peyvandi, Graham R Foster, et al.
Pediatric Blood & Cancer|June 1, 2012
Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenonYvonne E Chiu, Beth A Drolet, Francine Blei, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 19, 2023
Observational cohort study of long-term outcomes of liver transplantation in haemophiliaMargaret V Ragni, Jessica Callis, Nabil Daoud, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 25, 2019
Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS)Johnny Mahlangu, Johannes Oldenburg, Michael U Callaghan, et al.
Journal of Blood Medicine|October 28, 2021
Integrated Hemophilia Patient Care via a National Network of Care Centers in the United States: A Model for Rare Coagulation DisordersLeonard A Valentino, Judith R Baker, Regina Butler, et al.
Blood Advances|December 9, 2022
Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapyAnnette von Drygalski, Esteban Gomez, Adam Giermasz, et al.
Transfusion|May 11, 2013
Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentratesJ Michael Soucie, Paul E Monahan, Roshni Kulkarni, et al.
Transfusion|September 25, 2012
Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screeningJ Michael Soucie, Christine De Staercke, Paul E Monahan, et al.
Journal of Thrombosis and Haemostasis : JTH|June 30, 2022
Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United StatesJill M Johnsen, Shelley N Fletcher, Angela Dove, et al.
Pageof 14